2011
DOI: 10.1016/j.jaad.2010.03.027
|View full text |Cite
|
Sign up to set email alerts
|

The use of brachytherapy in the treatment of nonmelanoma skin cancer: A review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
60
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 85 publications
(64 citation statements)
references
References 26 publications
1
60
0
Order By: Relevance
“…With LDR interstitial brachytherapy, patients must be hospitalized throughout treatment, which may limit the circumstances under which this modality is used [14].…”
Section: Indications For Radiotherapy In Nmscmentioning
confidence: 99%
See 3 more Smart Citations
“…With LDR interstitial brachytherapy, patients must be hospitalized throughout treatment, which may limit the circumstances under which this modality is used [14].…”
Section: Indications For Radiotherapy In Nmscmentioning
confidence: 99%
“…The three mainstay treatment modalities for external beam therapy are orthovoltage RT, electron beam RT, and megavoltage photons [13]. Brachytherapy has been applied as a surface mold or implanted interstitially [14]. As we will see in a later section, there are also newer technologies, such as electronic brachytherapy, which represent additional tools in the clinician's arsenal [15].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…112 Of course, much has changed since those pioneering days, but the principle of applying a radiation source to the skin to kill tumour cells is still as valid today. Nonmelanoma skin cancers are the most common among the Caucasian population, 113 with almost 100,000 cases diagnosed in the UK alone each year. There are many different treatment modalities, including surgery, megavoltage X-rays and electrons and orthovoltage X-rays, but the inherent advantages of brachytherapy and the dominance of the inverse square law results in a rapid fall-off in doses beyond the tumour enabling skin lesions to be treated with tumourcidal doses, while sparing the sensitive, underlying structures.…”
Section: 103mentioning
confidence: 99%